drugset / Trial / NCT05490082
Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation
RandomizedParallel-groupDouble-blindTreatment
Summary
A randomized controlled study to compare the efficacy of mirabegron, solifenacin and propevirine for treatment of Lower urinary tract symptoms during intravesical BCG installation
Timeline
- Start
- 2022-03-01
- Primary completion
- 2023-03
- Completion
- 2023-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mirabegron | Other / unclassified | 50 mg | Oral |
| Comparator | Propevirine | Unknown | 15 mg | Oral |
| Comparator | Solifenacin | Small molecule | 10 mg | Oral |